NCT03741296

Brief Summary

Hip replacement surgery is common, with over 60,000 cases in Canada annually. After hip replacement, about 1-2% patients develop a deep infection in their artificial hip implant, called a periprosthetic joint infection (PJI). It can results in severe pain, disability and death. There are two types of surgical treatment: a single-stage revision that involves removing the joint, thoroughly cleaning the infected area and implanting a new joint, all in the same surgical procedure; a two-stage revision involves removing the joint, waiting at least 8 weeks while treating the patients with antibiotics and then doing re-implantation of the joint.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
110

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2019

Longer than P75 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 7, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 14, 2018

Completed
5 months until next milestone

Study Start

First participant enrolled

April 1, 2019

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2021

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

November 14, 2018

Status Verified

November 1, 2018

Enrollment Period

2.4 years

First QC Date

November 7, 2018

Last Update Submit

November 12, 2018

Conditions

Keywords

Hip replacementperiprosthetic hip infectionsingle stage revisiontwo-stage revision

Outcome Measures

Primary Outcomes (1)

  • Patient-reported hip function

    Measured by means of the Oxford Hip Score - A short questionnaire consists of 12 questions ranging from 0 to 48 points, designed to assess function and pain after hip replacement surgery. Higher values represent a better outcome. Scores between 40-48 indicate satisfactory joint function

    Questionnaire will be completed by patients at 9 months after surgery

Secondary Outcomes (6)

  • Health status and quality of life

    Questionnaire will be completed by patients before the surgery and at 6, 9, 12 and 24 months after surgery

  • Reinfection rates

    will be assessed at 6 weeks, 3, 6, 9,12 and 24 months after surgery

  • Patient-reported hip function

    Questionnaire will be completed by patients at 12 and 24 months after surgery

  • Visual Analog Pain Scale

    Pain scale will be assessed before the surgery and at 24 and 48 hours, 6 weeks, 3,6, 9, 12 and 24 months after surgery

  • Hospital readmission

    Will be assessed within 30 days of discharge

  • +1 more secondary outcomes

Study Arms (2)

single stage revision

ACTIVE COMPARATOR

One surgery where the infected artificial joint will be removed along with all components, cement, and any potentially infected material. The surgical site will be debrided and washed out before a new artificial hip joint (prosthesis) is implanted. All the procedures will be done in a single surgery.

Procedure: Single stage revision

two-stage revision

ACTIVE COMPARATOR

Patients will undergo 2 separated surgeries. In the first operation, the infected artificial joint will be removed along with all components, cement, and any potentially infected material. The surgical site will be debrided, washed out and a spacer will be placed in the hip (temporarily replace prosthesis). A secondary surgery to re-implant the hip will be performed with an interval period of 4-10 weeks when the infection is cleared. The site will be debrided and irrigated, and any component/spacer will be removed. A new artificial joint will then be implanted.

Procedure: Two-stage revision

Interventions

One-stage exchange hip joint replacement surgery

single stage revision

Two-stage exchange hip joint replacement surgery

two-stage revision

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female patients aged 18 years or above
  • A clinical diagnosis of deep hip periprosthetic joint infection according to the Musculoskeletal Infection Society criteria
  • Require revision surgery (either single-or two-stage revision) for hip periprosthetic joint infection in the opinion of the treating consultant orthopaedic surgeon
  • The patient is not a candidate for Debridement, Antibiotics and Implant Retention (DAIR) treatment with retention of the implant
  • Willing and able to sign the written consent, follow the protocol and attend follow-up
  • Able to read and understand English

You may not qualify if:

  • Culture-negative infection (organism not identified)
  • Patients with systemic sepsis who require emergent surgery
  • Resistant organisms not sensitive to available intravenous antibiotics
  • Revision surgery or previous two-stage reimplant
  • Unable or unwilling to undergo either single-or two-stage revision surgery
  • Cognitive impairment (dementia, Alzheimer, etc.) which will prevent patients from completing the primary outcome measure
  • Medical contra-indication to surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (10)

  • Kunutsor SK, Whitehouse MR, Blom AW, Beswick AD; INFORM Team. Re-Infection Outcomes following One- and Two-Stage Surgical Revision of Infected Hip Prosthesis: A Systematic Review and Meta-Analysis. PLoS One. 2015 Sep 25;10(9):e0139166. doi: 10.1371/journal.pone.0139166. eCollection 2015.

    PMID: 26407003BACKGROUND
  • Lopez D, Leach I, Moore E, Norrish AR. Management of the Infected Total Hip Arthroplasty. Indian J Orthop. 2017 Jul-Aug;51(4):397-404. doi: 10.4103/ortho.IJOrtho_307_16.

    PMID: 28790468BACKGROUND
  • Kapadia BH, Berg RA, Daley JA, Fritz J, Bhave A, Mont MA. Periprosthetic joint infection. Lancet. 2016 Jan 23;387(10016):386-394. doi: 10.1016/S0140-6736(14)61798-0. Epub 2015 Jun 28.

    PMID: 26135702BACKGROUND
  • Dale H, Fenstad AM, Hallan G, Havelin LI, Furnes O, Overgaard S, Pedersen AB, Karrholm J, Garellick G, Pulkkinen P, Eskelinen A, Makela K, Engesaeter LB. Increasing risk of prosthetic joint infection after total hip arthroplasty. Acta Orthop. 2012 Oct;83(5):449-58. doi: 10.3109/17453674.2012.733918.

    PMID: 23083433BACKGROUND
  • Blom AW, Taylor AH, Pattison G, Whitehouse S, Bannister GC. Infection after total hip arthroplasty. The Avon experience. J Bone Joint Surg Br. 2003 Sep;85(7):956-9. doi: 10.1302/0301-620x.85b7.14095.

    PMID: 14516026BACKGROUND
  • Phillips JE, Crane TP, Noy M, Elliott TS, Grimer RJ. The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospective survey. J Bone Joint Surg Br. 2006 Jul;88(7):943-8. doi: 10.1302/0301-620X.88B7.17150.

    PMID: 16799001BACKGROUND
  • Lenguerrand E, Whitehouse MR, Beswick AD, Jones SA, Porter ML, Blom AW. Revision for prosthetic joint infection following hip arthroplasty: Evidence from the National Joint Registry. Bone Joint Res. 2017 Jun;6(6):391-398. doi: 10.1302/2046-3758.66.BJR-2017-0003.R1.

    PMID: 28642256BACKGROUND
  • Chen SY, Hu CC, Chen CC, Chang YH, Hsieh PH. Two-Stage Revision Arthroplasty for Periprosthetic Hip Infection: Mean Follow-Up of Ten Years. Biomed Res Int. 2015;2015:345475. doi: 10.1155/2015/345475. Epub 2015 Apr 29.

    PMID: 26064901BACKGROUND
  • Kunutsor SK, Whitehouse MR, Blom AW, Board T, Kay P, Wroblewski BM, Zeller V, Chen SY, Hsieh PH, Masri BA, Herman A, Jenny JY, Schwarzkopf R, Whittaker JP, Burston B, Huang R, Restrepo C, Parvizi J, Rudelli S, Honda E, Uip DE, Bori G, Munoz-Mahamud E, Darley E, Ribera A, Canas E, Cabo J, Cordero-Ampuero J, Redo MLS, Strange S, Lenguerrand E, Gooberman-Hill R, Webb J, MacGowan A, Dieppe P, Wilson M, Beswick AD; Global Infection Orthopaedic Management Collaboration. One- and two-stage surgical revision of peri-prosthetic joint infection of the hip: a pooled individual participant data analysis of 44 cohort studies. Eur J Epidemiol. 2018 Oct;33(10):933-946. doi: 10.1007/s10654-018-0377-9. Epub 2018 Apr 5.

    PMID: 29623671BACKGROUND
  • Kunutsor SK, Whitehouse MR, Lenguerrand E, Blom AW, Beswick AD; INFORM Team. Re-Infection Outcomes Following One- And Two-Stage Surgical Revision of Infected Knee Prosthesis: A Systematic Review and Meta-Analysis. PLoS One. 2016 Mar 11;11(3):e0151537. doi: 10.1371/journal.pone.0151537. eCollection 2016.

    PMID: 26967645BACKGROUND

Study Officials

  • Amit Atrey, MD

    Unity Health Toronto

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Luana Melo, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a study is a multicentre, prospective, parallel, two-arm, randomized controlled trial aiming to assess the efficacy of single stage revision peri-prosthetic joint infection of hip arthroplasty in adult's patients, compared to the current gold standard of care, two-stage revision.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 7, 2018

First Posted

November 14, 2018

Study Start

April 1, 2019

Primary Completion

September 1, 2021

Study Completion

December 1, 2022

Last Updated

November 14, 2018

Record last verified: 2018-11